Utility Menu French

National Association of Pharmacy Regulatory Authorities

Provinces French

Main navigation French


Recherchez dans la base de données des Annexes nationales de médicaments

Commencez votre recherche en utilisant le nom générique du produit :

Recherche par annexe
Réinitialiser

ATTENTION : Tous les résultats de la recherche seront tirés du « National Drug Schedules » du site Web en anglais.

Nom du médicament (en anglais) Commentaire Annexe Date
Abacavir or its saltsPDL I DEC / 13
AbataceptPDL I DEC / 13
AbciximabPDL I DEC / 13
Abemaciclib or its saltsPDL I JUL / 19
Abiraterone or its derivativesPDL

including but not limited to abiraterone acetate

I DEC / 13
Acalabrutinib or its saltsPDL I OCT / 19
Acamprosate or its saltsPDL I DEC / 13
Acarbose or its derivativesPDL I DEC / 13
Acebutolol or its saltsPDL I DEC / 13
Acepromazine or its saltsPDL

for human use

I DEC / 13
AcetaminophenPDL

when recommended for administration by intravenous injection

I DEC / 13
Acetaminophen and ibuprofen

When sold in oral, fixed-dose combinations, in package sizes containing 20,000 mg or less of acetaminophen and 6,000 mg or less of ibuprofen*
*Note that this listing does not apply to products containing ibuprofen that would meet the criteria to be included on the Prescription Drug list, as these would require a prescription

III JUL / 20
Acetaminophen and ibuprofen.

When sold in oral, fixed-dose combinations, in package sizes containing either more than 20,000 mg of acetaminophen or more than 6,000 mg of ibuprofen*
*Note that this listing does not apply to products containing ibuprofen that would meet the criteria to be included on the Prescription Drug list, as these would require a prescription

II JUL / 20
Acetaminophen in sustained release formulations

up to and including 650 mg per unit, in package sizes containing no more than 50 units

U JAN / 03
Acetaminophen in sustained release formulations.

in strengths of greater than 650 mg per unit or in package sizes of more than 50 units

III JAN / 03
Acetaminophen. in immediate release tablets, capsules, suppositories or liquid U SEP / 99
AcetanilidePDL

for human use

I DEC / 13
Acetarsol II SEP / 98
AcetazolamidePDL I DEC / 13
AcetohexamidePDL I DEC / 13
AcetorphineN I JUN / 02
Acetyl-a-methylfentanylN I JUN / 02
AcetylcarbromalPDL I DEC / 13
Acetylcholine ChloridePDL I DEC / 13
Acetylcysteine II SEP / 98
AcetyldihydrocodeineN I JUN / 02
AcetylmethadolN I JUN / 02
Acetylsalicylic acid and its salts oral preparations containing 80 mg or less per dosage unit and intended for pediatric use or rectal preparations containing 150 mg or less per dosage unit, in package sizes containing no more than 1.92 g of acetylsalicylic acid. II FEB / 02
Acetylsalicylic acid and its salts. in products for oral use in strengths of 325mg and 500mg per dosage unit U OCT / 00
Acetylsalicylic acid and its salts.. in products intended for oral adult use in strengths of 81 mg per dosage unit and 650 mg or greater per dosage unit, and in rectal preparations containing more than 150 mg per dosage unit III OCT / 00
Acitretin or its salts or derivativesPDL I DEC / 13
Aclidinium or its saltsPDL I DEC / 13
Aconiazide or its saltsPDL I DEC / 13
Acyclovir or its saltsPDL I DEC / 13
AdalimumabPDL I DEC / 13
Adapalene or its salts or derivativesPDL I DEC / 13
Adefovir or its salts or derivativesPDL

including but not limited to adefovir dipivoxil

I DEC / 13
Adenosine or its saltsPDL

when sold or recommended for administration by intravenous injection

I DEC / 13
Adiphene and its salts for parenteral use II SEP / 98
Adrenocortical hormones or their salts or derivativesPDL

for human use including but not limited to: Betamethasone valerate, betamethasone sodium, betamethasone phosphate, betamethasone dipropionate, budesonide, ciclesonide, clobetasone, cortisone, dexamethasone sodium, dexamethasone phosphate, dexamethasone acetate, difluprednate, fludrocortisone acetate, flunisolide, fluticasone propionate, fluticasone furoate, hydrocortisone acetate, hydrocortisone aceponate, hydrocortisone sodium, methylprednisolone acetate, methylprednisolone, methylprednisolone succinate, methylprednisolone sodium, mometasone furoate, prednisolone acetate, prednisolone sodium, prednisolone phosphate, prednisone, triamcinolone acetonide, triamcinolone hexacetonide except: (a) hydrocortisone or hydrocortisone acetate, when sold as a single medicinal ingredient in a concentration that provides 1.0% or less hydrocortisone in preparations for topical use on the skin; or (b) hydrocortisone or hydrocortisone acetate, when sold in combination with any other nonprescription medicinal ingredient that provides 1.0% or less hydrocortisone in preparations for topical use on the skin; or (c) clobetasone butyrate when sold in a concentration of 0.05% in cream preparations for topical use on the skin; or (d) triamcinolone acetonide in a nasal spray that delivers 55 microgram (mcg)/spray for those 12 years of age and older; or, (e) mometasone furoate for the treatment of allergic rhinitis in a nasal spray that delivers 50 mcg/spray for those 12 years of age and older; or (f) fluticasone propionate for the treatment of allergic rhinitis in a nasal spray that delivers 50 microgram/spray for those 18 years of age and older.

I AUG / 16
Afatinib or its saltsPDL I DEC / 13
AfliberceptPDL I DEC / 13
AfoxolanerPDL I AUG / 14
Agalsidase AlfaPDL I APR / 07
Agalsidase BetaPDL I DEC / 14
AlbiglutidePDL I AUG / 15
AldesleukinPDL I DEC / 13
Alectinib or its saltsPDL I NOV / 16
AlefaceptPDL I DEC / 13
AlemtuzumabPDL I DEC / 13
Alendronic acid or its saltsPDL I DEC / 13
AlfacalcidolPDL I DEC / 13
AlfentanilN I JUN / 02
Alfuzosin or its saltsPDL I DEC / 13
Alglucosidase alfaPDL I DEC / 13
AlirocumabPDL I AUG / 16
Aliskiren or its saltsPDL I DEC / 13
Alitretinoin or its salts or derivativesPDL I DEC / 13
Alkyl nitritesPDL I DEC / 13
Allergy serums and extracts I SEP / 99
Allethrins II SEP / 98
AllobarbitalC2 I JUN / 02
AllopurinolPDL I DEC / 13
AllylisopropylacetylureaPDL I DEC / 13
AllylprodineN I JUN / 02
Almotriptan or its saltsPDL I DEC / 13
Alogliptin or its salts or its derivativesPDL I DEC / 13
Alpelisib or its saltsPDL I JUL / 20
Alpha-chloralosePDL I DEC / 13
Alpha-hydroxy acidsPDL

including but not limited to citric acid, glycolic acid, lactic acid, malic acid, mandelic acid, ammonium glycolate, glycolic acid + ammonium glycolate, alpha-hydroxyethanoic acid + ammonium alpha-hydroxyethanoate, alpha-hydroxyoctanoic acid, alpha-hydroxycaprylic acid, hydroxycaprylic acid, mixed fruit acid, triple fruit acid, tri-alpha hydroxy fruit acids, alpha hydroxy and botanical complex, l-alpha hydroxy acid, glycomer in cross-linked fatty acids alpha nutrium, when sold in topical formulations containing alpha hydroxy acids alone or in combination at concentrations of greater than 30% and/or with a pH lower than 3.0, except when sold to be applied to warts, corns or calluses

I DEC / 14
AlphacetylmethadolN I JUN / 02
Alphadolone or its saltsPDL I DEC / 13
AlphameprodineN I JUN / 02
AlphamethadolN I JUN / 02
AlphaprodineN I JUN / 02
AlphaxalonePDL

including but not limited to alfaxalone, alphaxolone

I DEC / 13
AlprazolamTS I SEP / 98
Alteplase or its salts or derivativesPDL

including but not limited to tenecteplase

I DEC / 13
AltrenogestPDL I DEC / 13
AltretaminePDL I DEC / 13
Alverine and its salts for parenteral use I SEP / 98
Amantadine or its saltsPDL I DEC / 13
Ambenonium ChloridePDL I DEC / 13
AmbrisentanPDL I DEC / 13
Amifampridine or its salts or derivatives PDL I SEP / 20
Amifostine or its saltsPDL I DEC / 13
Amikacin or its salts or derivativesPDL

PDL, including but not limited to amikacin sulfate

I DEC / 13
Amiloride or its saltsPDL I DEC / 13
Amino Acid solutions for parenteral use I SEP / 99
4- Amino-pteroyl aspartic acid or its saltsPDL I DEC / 13
Aminocaproic acidPDL I DEC / 13
AminoglutethimidePDL I DEC / 13
Aminolevulinic acid or its salts or derivativesPDL I DEC / 13
AminophyllinePDL I DEC / 13
Aminopromazine [proquamezine] and its salts I SEP / 98
Aminopterin or its salts or derivativesPDL I DEC / 13
Aminopyrine or its derivativesPDL

for human use

I DEC / 13
Aminorex, its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analoguesC1

Including 4-Methylaminorex and 4,4'-Dimethylaminorex.

I DEC / 17
4- Aminosalicylic Acid or its saltsPDL I DEC / 13
5- Aminosalicylic acidPDL

including but not limited to mesalazine

I DEC / 13

1977 résultats


Footnotes

  • C - Drug is listed in the Schedule to Part G of the Food and Drug Regulations under the Controlled Drugs and Substances Act
    N - Drug is listed in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
    NR - Drug has not been reviewed by the NDSAC
    PDL - Drug is listed in the Health Canada Prescription Drug List
    TS - Drug is listed in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
    CR - Drug has been recommended for addition to the Controlled Drugs and Substances Act